Firmagon (Degarelix) Intermittent Therapy (FIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01512472
Recruitment Status : Terminated (acrrual target was not being met)
First Posted : January 19, 2012
Last Update Posted : October 14, 2016
Ferring Pharmaceuticals
Information provided by (Responsible Party):
Canadian Urology Research Consortium

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2017